-+ 0.00%
-+ 0.00%
-+ 0.00%

DIANTHUS THERAPEUTICS- PROPOSED CHANGES TO SCREENING CRITERIA RELATED TO CLASEPRUBART TRIALS TO FDA IN Q1 2026 - SEC FILING

Reuters·03/26/2026 12:08:59

Please log in to view news